Novo Nordisk A/S (NVO) Reports 8% Weight Loss in Phase 3a Obesity Trial With liraglutide 3 mg
5/23/2013 11:32:37 AM
More...
|
Novo Nordisk A/S (NVO) Reports Positive Results From First Phase 3 Trial With Long-Acting Factor IX for Treatment of Hemophilia B
5/17/2013 10:18:53 AM
More...
|
Novo Nordisk A/S (NVO) Invests $69 Million in Plant, Creating 50 New Production/Engineering Jobs
5/7/2013 7:35:35 AM
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
5/6/2013 11:11:49 AM
More...
|
Novo Nordisk A/S (NVO) Purchases B Shares Worth DKK 2.5 Billion From Novo A/S as Part of the On-Going Share Repurchase Program
5/6/2013 10:47:28 AM
More...
|
Novo Nordisk A/S (NVO) Increased Operating Profit by 18 Pct in the First Quarter of 2013
5/1/2013 11:50:11 AM
More...
|
Total Number of Voting Rights and Share Capital in Novo Nordisk A/S (NVO) as of 30 April 2013
4/30/2013 11:44:57 AM
More...
|
Novo Nordisk A/S (NVO) - Share Repurchase Program
4/30/2013 11:41:06 AM
More...
|
Emisphere Technologies, Inc. (EMIS), Novo Nordisk A/S (NVO) Amend Drug Development Agreement With $10 Million Payment
4/29/2013 8:51:17 AM
More...
|
Novo Nordisk A/S (NVO): Reduction of the Share Capital
4/22/2013 12:17:10 PM
More...
|
|